Trinity Biotech PLC (TRIB)
1.56
+0.01
(+0.65%)
USD |
NASDAQ |
May 22, 16:00
1.60
+0.04
(+2.56%)
After-Hours: 20:00
Trinity Biotech Cash from Operations (Quarterly): 0.242M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.242M |
| September 30, 2023 | -4.664M |
| June 30, 2023 | -4.417M |
| March 31, 2023 | -2.718M |
| December 31, 2022 | 1.831M |
| September 30, 2022 | 0.676M |
| June 30, 2022 | -1.935M |
| March 31, 2022 | -1.493M |
| December 31, 2021 | 4.33M |
| September 30, 2021 | 1.697M |
| June 30, 2021 | 1.128M |
| March 31, 2021 | 6.083M |
| December 31, 2020 | 12.47M |
| September 30, 2020 | 7.031M |
| June 30, 2020 | 5.646M |
| March 31, 2020 | -1.396M |
| December 31, 2019 | -3.637M |
| September 30, 2019 | 4.633M |
| June 30, 2019 | 4.949M |
| March 31, 2019 | -0.528M |
| December 31, 2018 | 1.978M |
| September 30, 2018 | 2.934M |
| June 30, 2018 | 1.534M |
| March 31, 2018 | 0.783M |
| December 31, 2017 | 1.509M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.071M |
| June 30, 2017 | 3.434M |
| March 31, 2017 | 0.236M |
| December 31, 2016 | 1.01M |
| September 30, 2016 | 5.386M |
| June 30, 2016 | 2.198M |
| March 31, 2016 | 1.634M |
| December 31, 2015 | 7.821M |
| September 30, 2015 | 2.464M |
| June 30, 2015 | 1.003M |
| March 31, 2015 | 1.868M |
| December 31, 2014 | 8.898M |
| September 30, 2014 | 5.207M |
| June 30, 2014 | 1.171M |
| March 31, 2014 | 0.783M |
| December 31, 2013 | 0.431M |
| September 30, 2013 | 3.407M |
| June 30, 2013 | 2.461M |
| March 31, 2013 | 3.058M |
| December 31, 2012 | 5.88M |
| September 30, 2012 | 5.446M |
| June 30, 2012 | 4.866M |
| March 31, 2012 | 3.769M |
| December 31, 2011 | 4.257M |
| September 30, 2011 | 5.111M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.664M
Minimum
Sep 2023
12.47M
Maximum
Dec 2020
1.603M
Average
1.128M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Avadel Pharmaceuticals PLC | -29.70M |
| Amarin Corp PLC | -12.60M |
| DBV Technologies SA | -34.69M |
| Adaptimmune Therapeutics PLC | -31.95M |
| Akari Therapeutics PLC | -4.044M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.891M |
| Cash from Financing (Quarterly) | -1.763M |
| Free Cash Flow | -14.26M |
| Free Cash Flow Per Share (Quarterly) | -0.0513 |
| Free Cash Flow to Equity (Quarterly) | -1.016M |
| Free Cash Flow to Firm (Quarterly) | 1.076M |
| Free Cash Flow Yield | -100.1% |